Related Experiment Videos
[Coronary insufficiency and diabetes]
Insights
Diabetics with myocardial infarct face double the mortality risk within a month. Early glycosylated hemoglobin testing aids diabetes diagnosis during heart attacks, highlighting preventable causes.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Cardiovascular diseases are the leading cause of premature death in diabetic patients.
- Diabetic patients often succumb to cardiovascular events in intensive care or cardiology settings, not diabetes clinics.
- Coronary insufficiency in diabetics presents unique clinical and prognostic characteristics.
Purpose of the Study:
- To highlight the increased mortality risk in diabetic patients post-myocardial infarct.
- To emphasize the diagnostic role of glycosylated hemoglobin in acute myocardial infarction.
- To discuss the specificities and therapeutic approaches for cardiovascular issues in diabetics.
Main Methods:
- Review of mortality data for diabetic patients following myocardial infarction.
- Analysis of diagnostic markers for diabetes in the acute phase of myocardial infarction.
- Comparison of clinical presentation and prognosis of coronary insufficiency in diabetics versus non-diabetics.
Main Results:
- Diabetic patients experience double the mortality rate in the first month after myocardial infarction compared to the general population.
- Glycosylated hemoglobin is identified as the optimal diagnostic indicator for diabetes during the acute phase of myocardial infarction.
- While cardiovascular problems in diabetics share therapeutic similarities with non-diabetics, their clinical presentation and prognosis are distinct.
Conclusions:
- Diabetic patients face significantly higher mortality risks after myocardial infarction, with some causes being preventable.
- Early diagnosis of diabetes using glycosylated hemoglobin is crucial during acute myocardial infarction.
- Understanding the specific clinical and prognostic aspects of coronary insufficiency in diabetics is essential for effective management, despite shared therapeutic strategies.
Abstract:
Cardiovascular diseases represent the major cause of premature death in diabetics. These patients usually die in an intensive care unit or a cardiological clinic, not in a diabetic clinic. In the acute phase of a myocardial infarct the determination of glycosylated haemoglobin is the best indicator for the diagnosis of diabetes. During the first month after the myocardial infarct the mortality among diabetics is double that of the general population. The causes of this phenomenon are multiple, some of which may be prevented. In the case of diabetics coronary insufficiency is characterised by an unquestionable clinical and prognostic specificity whereas, from the therapeutic point of view, the purely cardiological problems are identical with those found in non-diabetics.